| 21-May-13 08:18AM | Neuralstem: Update On Phase I Trial Of Neural Stem Cells In ALS Is Encouraging at Seeking Alpha |
| 20-May-13 11:38AM | A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013 at Seeking Alpha |
| 09:17AM | InPlay: Neuralstem: ALS trial principal investigator presents Phase I data; data shows early stem cell transplantation could slow progression or even improve patient's condition in some forms of ALS Briefing.com |
| 09:15AM | Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania PR Newswire |
| 19-May-13 08:32PM | SmithOnStocks Opines On Stocks: May 19th Edition at Seeking Alpha |
| 11:52AM | Cloning: A Stem Cell Revolution? at Motley Fool |
| 17-May-13 01:04PM | NEURALSTEM, INC. Financials EDGAR Online Financials |
| 16-May-13 11:49AM | Smaller Companies With Potential For Big Returns at Seeking Alpha +11.54% |
| 11:49AM | Smaller Companies With Great Potential For Big Returns at Seeking Alpha |
| 09:55AM | Neuralstem: Update On ALS Trial Could Be A Catalyst For The Stock at Seeking Alpha |
| 09:15AM | Neuralstem CEO, Richard Garr, To Present At Annual World Stem Cells And Regenerative Medicine Congress In London PR Newswire |
| 07:56AM | Neuralstem Rounding Second With Phase II ALS Trial at Seeking Alpha |
| 13-May-13 09:15AM | Neuralstem Principal Investigator, Dr. Eva Feldman, Presents Phase I ALS Trial Data At The Romanian Neurological Society Congress PR Newswire |
| 05:38AM | SmithOnStocks Opines On Recent Biotech News at Seeking Alpha |
| 10-May-13 04:24PM | Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update PR Newswire |
| 09:59AM | NEURALSTEM, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online |
| 09:03AM | NEURALSTEM, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 09-May-13 01:46PM | 5 Stocks Under $10 Set to Soar at TheStreet +6.45% |
| 08-May-13 11:06PM | NEURALSTEM, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events EDGAR Online +5.98% |
| 09:15AM | Neuralstem ALS Trial Investigator And Patient On Sirius XM PR Newswire |
| 07-May-13 02:07PM | Neuralstem: Anticipating More Efficacy Data From ALS Trial And Update On New Clinical Trials at Seeking Alpha |
| 02-May-13 08:11AM | StemCells Inc: CEO Martin McGlynn Is Building A Blockbuster Company at Seeking Alpha |
| 01-May-13 05:33AM | Stem Cells: Invest At Your Own Peril at Seeking Alpha |
| 29-Apr-13 11:16AM | InPlay: Neuralstem ALS trial data presented at the American Association Of Neurological Surgeons Annual Meeting; method of intraspinal cell delivery found to be safe, well-tolerated, and promising for other spinal cord conditions Briefing.com |
| 11:15AM | Neuralstem ALS Trial Data Presented At The American Association Of Neurological Surgeons Annual Meeting PR Newswire |
| 28-Apr-13 01:34AM | Regenerative Medicine's Time Has Come at Seeking Alpha |
| 26-Apr-13 09:10AM | NEURALSTEM, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 24-Apr-13 01:59PM | NFL group, company teaming up for brain drug test AP +9.57% |
| 09:15AM | Neuralstem And The National Football League Alumni Association Announce Initiative On Brain Injury Treatment PR Newswire |
| 22-Apr-13 09:16AM | NEURALSTEM, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 09:16AM | InPlay: Neuralstem announces FDA approves Neuralstem to treat final cohort in NSI-189 Phase Ib trial In Major Depressive Disorder Briefing.com |
| 09:15AM | FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder PR Newswire |
| 18-Apr-13 05:07PM | 4 Healthcare Stock Stories for Thursday Investment Wellness at Wall St. Cheat Sheet |
| 09:15AM | Neuralstem CEO, Richard Garr, To Participate In Traumatic Brain Injury Panel At BIO International Convention PR Newswire |
| 17-Apr-13 02:22PM | 2 Biotech Stocks Announcing Key Early Stage Clinical Developments at Seeking Alpha +8.49% |
| 08:36AM | Investing In The Stem Cell Sector: An Overview at Seeking Alpha |
| 08:02AM | InPlay: Neuralstem receives FDA approval to commence Phase II Stem Cell trial in Amytrophic Lateral Sclerosis Briefing.com |
| 08:02AM | Neuralstem Receives FDA Approval To Commence Phase II Stem Cell Trial In Amytrophic Lateral Sclerosis PR Newswire |
| 10-Apr-13 04:00AM | The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy at Seeking Alpha |
| 08-Apr-13 06:56AM | NEURALSTEM, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 05-Apr-13 09:15AM | InPlay: Neuralstem receives notice of allowance of patent covering use of stem cells to treat amyotrophic lateral sclerosis Briefing.com |
| 09:15AM | Neuralstem Receives Notice Of Allowance Of Patent Covering Use Of Stem Cells To Treat Amyotrophic Lateral Sclerosis PR Newswire |
| 01-Apr-13 12:36PM | Updating A Speculative Idea And Sharing A New One at Seeking Alpha |
| 28-Mar-13 09:14AM | Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy at Seeking Alpha |
| 27-Mar-13 10:22AM | NEURALSTEM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Oblig EDGAR Online |
| 06:35AM | Buy Hercules Tech Growth Capital Instead Of OCZ Tech at Seeking Alpha |
| 26-Mar-13 08:42AM | Hercules Technology Growth Capital Tilts To Life Sciences at Forbes |
| 25-Mar-13 09:17AM | InPlay: Neuralstem secures $8 mln in debt financing from Hercules (HTGC) Briefing.com |
| 09:15AM | Neuralstem Secures $8 Million In Debt Financing From Hercules PR Newswire |
| 21-Mar-13 01:04PM | NEURALSTEM, INC. Financials EDGAR Online Financials |
| 12:23PM | Neuralstem Update Fails To Excite, All Eyes On Upcoming Phase II Trial at Seeking Alpha |
| 20-Mar-13 11:46AM | Neuralstem President and CEO, Richard Garr Publishes New Blog Post Titled ''The Best Thing About the Future is that It Comes One Day at a Time'' Accesswire |
| 18-Mar-13 07:20PM | New Star Analyst Rankings for Neuralstem, Inc. Common Stock StarMine |
| 11:03AM | Neuralstem: A Top Regenerative Medicine Play at Seeking Alpha |
| 17-Mar-13 07:16PM | New Star Analyst Rankings for Neuralstem, Inc. Common Stock StarMine |
| 15-Mar-13 03:57PM | NEURALSTEM, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online |
| 09:22AM | Neuralstem sees filing IND for spinal cord trial in South Korea this month theflyonthewall.com |
| 09:15AM | Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update PR Newswire |
| 14-Mar-13 09:02AM | Neuralstem CEO, Richard Garr, Named To "Top 50 Global Stem Cell Influencers" PR Newswire |
| 11-Mar-13 06:33AM | Valuing Amarantus - Where Financial Reality Meets Scientific Hope at Seeking Alpha |
| 07-Mar-13 08:20AM | ALS Crisis Of Conscience At FDA Spells Opportunity For Neuralstem, Brainstorm at Seeking Alpha +8.55% |
| 06-Mar-13 08:20AM | Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High Marketwire |
| 05-Mar-13 05:42AM | After Successful ALS Phase I, Neuralstem Branches Out at Seeking Alpha |
| 22-Feb-13 11:06AM | Regenerative Medicine: Some Realism Please at Seeking Alpha |
| 20-Feb-13 01:28PM | NEURALSTEM, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 09:15AM | Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center PR Newswire |
| 15-Feb-13 07:06AM | NEURALSTEM, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online |
| 08-Feb-13 12:03PM | Athersys: The Coming Year Will Define MultiStem, Its Adult Stem Cell Product at Seeking Alpha |
| 07:32AM | Insight On Advanced Cell Technology: An Interview With Gary Rabin, Chairman And CEO at Seeking Alpha |
| 07-Feb-13 09:00AM | Neuralstem President And CEO To Present At BIO CEO & Investor Conference 2013 PR Newswire |
| 22-Jan-13 09:33AM | 3 Regenerative Medicine Companies That Could Deliver In 2013 at Seeking Alpha |
| 19-Jan-13 12:04PM | This Week in Biotech at Motley Fool |
| 16-Jan-13 04:23PM | NEURALSTEM, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 02:35PM | Stem Cell Stocks To Consider: Aastrom, Athersys, StemCells And Neuralstem at Seeking Alpha |
| 15-Jan-13 12:45PM | The Race To Cure Spinal Cord Injuries at Seeking Alpha |
| 11:46AM | Neuralstem Inc. What the FDA's Approval Really Means for Neuralstem Accesswire |
| 11:46AM | Neuralstem Inc. What the FDA's Approval Really Means for Neuralstem |
| 10:55AM | FDA OKs Neuralstem Trial Treating Spinal Cord Injuries With Stem Cells at Motley Fool |
| 14-Jan-13 04:34PM | FDA clears study of Neuralstem spinal cord therapy AP |
| 03:46PM | 4 Healthcare Stock Stories Prescribed for Investors at Wall St. Cheat Sheet |
| 08:05AM | InPlay: Neuralstem receives FDA approval to commence spinal cord injury trial Briefing.com |
| 08:00AM | Neuralstem Receives FDA Approval To Commence Spinal Cord Injury Trial PR Newswire |
| 11-Jan-13 08:20AM | Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013 Marketwire |
| 09-Jan-13 06:35AM | Stem Cell Companies For Consideration In 2013 at Seeking Alpha |
| 06:06AM | NEURALSTEM, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online |
| 07-Jan-13 09:13AM | 2012 Breakthroughs In Cell Therapy Development at Seeking Alpha |
| 06-Jan-13 04:46PM | Weak Trading In Athersys Following Share Dilution at Seeking Alpha |
| 04-Jan-13 09:00AM | Neuralstem President and CEO to Present 2013 Trials Overview at 2013 Biotech Showcase PR Newswire +7.44% |
| 02-Jan-13 11:06AM | CAPScall of the Week: Neuralstem at Motley Fool +11.01% |
| 27-Dec-12 06:07AM | 6 Micro Caps To Add To Your Portfolio For 2013 at Seeking Alpha |
| 19-Dec-12 02:43PM | Neuralstem Shows ALS Can Be Beaten Back - Now On To Phase II at Seeking Alpha |
| 18-Dec-12 04:15PM | Pershing Gold: NOT a Daytrade but a Long-Term Investment at Forbes |
| 02:42PM | Pershing Gold: Not A Daytrade But A Long Term Investment at Seeking Alpha |
| 16-Dec-12 08:42AM | Biotech Under The Electron Microscope: What's In The Pipeline And Lessons To Be Learned at Seeking Alpha |
| 10-Dec-12 09:18AM | InPlay: Neuralstem presents new ALS NSI-566 data; researchers were able to establish the long-term survival of Neuralstem's transplanted spinal cord stem cells in autopsied patients Briefing.com |
| 09:15AM | Neuralstem Investigator Presents New ALS NSI-566 Data at International Symposium on ALS/MND PR Newswire |
| 09-Dec-12 10:16PM | Biotech Weekly Recap: The Market Holds While Biotech Crumbles at Seeking Alpha |
| 04-Dec-12 03:40PM | Investors Chase Neuralstem On Successful Phase I Trial at Seeking Alpha -19.46% |
| 10:03AM | Maxim Group Highlights 3 Stem Cells Stocks To Consider And 1 To Avoid at Seeking Alpha |
| 08:32AM | Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases Marketwire |
